Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0293 | 0.239 | 0.8345 | |
Echinococcus multilocularis | homeodomain interacting protein kinase 3 | 0.035 | 0.308 | 1 |
Echinococcus multilocularis | proto oncogene serine:threonine protein kinase | 0.033 | 0.284 | 0.9222 |
Echinococcus granulosus | protein kinase | 0.013 | 0.0417 | 0.1355 |
Loa Loa (eye worm) | STE/STE20/MSN protein kinase | 0.013 | 0.0417 | 0.0417 |
Trypanosoma brucei | kinetoplastid kinetochore protein 10 | 0.0131 | 0.0423 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0124 | 0.0337 | 0.797 |
Schistosoma mansoni | serine/threonine protein kinase | 0.033 | 0.284 | 0.534 |
Onchocerca volvulus | 0.0303 | 0.2507 | 0.8775 | |
Echinococcus granulosus | proto oncogene serine:threonine protein kinase | 0.033 | 0.284 | 0.9222 |
Trypanosoma cruzi | kinetoplastid kinetochore protein 10, putative | 0.0131 | 0.0423 | 1 |
Toxoplasma gondii | cell-cycle-associated protein kinase CLK, putative | 0.0131 | 0.0423 | 1 |
Loa Loa (eye worm) | CMGC/CLK protein kinase | 0.0131 | 0.0423 | 0.0423 |
Loa Loa (eye worm) | CDC7 protein kinase | 0.0124 | 0.0337 | 0.0337 |
Trypanosoma brucei | protein kinase, putative | 0.0106 | 0.012 | 0.2833 |
Brugia malayi | Homeodomain interacting protein kinase protein 1 | 0.035 | 0.308 | 0.308 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0106 | 0.012 | 0.0389 |
Giardia lamblia | Kinase, CMGC CLK | 0.0131 | 0.0423 | 1 |
Trypanosoma cruzi | kinetoplastid kinetochore protein 19, putative | 0.0131 | 0.0423 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0124 | 0.0337 | 0.0634 |
Onchocerca volvulus | 0.0124 | 0.0337 | 0.0799 | |
Brugia malayi | Protein kinase domain containing protein | 0.0131 | 0.0423 | 0.0423 |
Entamoeba histolytica | protein kinase, putative | 0.0106 | 0.012 | 0.0389 |
Giardia lamblia | Kinase, CMGC GSK | 0.0106 | 0.012 | 0.2833 |
Echinococcus multilocularis | 0.0121 | 0.0306 | 0.0995 | |
Echinococcus multilocularis | 0.013 | 0.0417 | 0.1355 | |
Echinococcus multilocularis | dual specificity protein kinase clk2 | 0.0131 | 0.0423 | 0.1374 |
Schistosoma mansoni | protein kinase | 0.0181 | 0.103 | 0.1937 |
Plasmodium falciparum | glycogen synthase kinase 3 | 0.0106 | 0.012 | 0.2833 |
Echinococcus granulosus | homeodomain interacting protein kinase 3 | 0.035 | 0.308 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0106 | 0.012 | 0.2833 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0131 | 0.0423 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0303 | 0.2507 | 0.4713 |
Trypanosoma cruzi | glycogen synthase kinase 3, putative | 0.0106 | 0.012 | 0.2833 |
Echinococcus granulosus | protein kinase shaggy | 0.0106 | 0.012 | 0.0389 |
Plasmodium vivax | glycogen synthase kinase 3, putative | 0.0106 | 0.012 | 0.2833 |
Echinococcus granulosus | hypothetical protein | 0.0121 | 0.0306 | 0.0995 |
Trypanosoma cruzi | kinetoplastid kinetochore protein 19, putative | 0.0131 | 0.0423 | 1 |
Schistosoma mansoni | glycogen synthase kinase 3-related (gsk3) (cmgc group III) | 0.0106 | 0.012 | 0.0225 |
Brugia malayi | Serine/threonine-protein kinase Pim-3 | 0.033 | 0.284 | 0.284 |
Trypanosoma cruzi | kinetoplastid kinetochore protein 10, putative | 0.0131 | 0.0423 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.0124 | 0.0337 | 0.0337 |
Trypanosoma brucei | kinetoplastid kinetochore protein 19 | 0.0131 | 0.0423 | 1 |
Echinococcus multilocularis | glycogen synthase kinase 3 beta | 0.0106 | 0.012 | 0.0389 |
Giardia lamblia | Kinase, CMGC GSK | 0.0106 | 0.012 | 0.2833 |
Loa Loa (eye worm) | hypothetical protein | 0.0121 | 0.0306 | 0.0306 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0131 | 0.0423 | 0.0796 |
Echinococcus multilocularis | protein kinase shaggy | 0.0106 | 0.012 | 0.0389 |
Plasmodium vivax | serine/threonine kinase-1, putative | 0.0131 | 0.0423 | 1 |
Loa Loa (eye worm) | CAMK/PIM protein kinase | 0.033 | 0.284 | 0.284 |
Echinococcus granulosus | CDC7 cell division cycle 7 | 0.0124 | 0.0337 | 0.1095 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0131 | 0.0423 | 0.0796 |
Echinococcus granulosus | glycogen synthase kinase 3 beta | 0.0106 | 0.012 | 0.0389 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0106 | 0.012 | 0.012 |
Toxoplasma gondii | cell-cycle-associated protein kinase GSK, putative | 0.0106 | 0.012 | 0.2833 |
Schistosoma mansoni | protein kinase | 0.013 | 0.0417 | 0.0784 |
Loa Loa (eye worm) | CAMK/PIM protein kinase | 0.033 | 0.284 | 0.284 |
Onchocerca volvulus | 0.0124 | 0.0337 | 0.0799 | |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0106 | 0.012 | 0.012 |
Loa Loa (eye worm) | hypothetical protein | 0.0171 | 0.0913 | 0.0913 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0106 | 0.012 | 0.0389 |
Echinococcus granulosus | serine:threonine protein kinase mig 15 | 0.0171 | 0.0913 | 0.2966 |
Echinococcus multilocularis | CDC7 cell division cycle 7 | 0.0124 | 0.0337 | 0.1095 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0106 | 0.012 | 0.2833 |
Brugia malayi | Protein kinase domain containing protein | 0.0409 | 0.3794 | 0.3794 |
Leishmania major | protein kinase, putative | 0.0131 | 0.0423 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.033 | 0.284 | 0.284 |
Echinococcus granulosus | dual specificity protein kinase clk2 | 0.0131 | 0.0423 | 0.1374 |
Echinococcus granulosus | rho-associated protein kinase 1 | 0.0303 | 0.2507 | 0.814 |
Giardia lamblia | Kinase, CDC7 | 0.0124 | 0.0337 | 0.797 |
Leishmania major | glycogen synthase kinase, putative;with=GeneDB:LinJ18_V3.0270 | 0.0106 | 0.012 | 0.2833 |
Loa Loa (eye worm) | AGC/DMPK/ROCK protein kinase | 0.0921 | 1 | 1 |
Brugia malayi | intracellular kinase | 0.0106 | 0.012 | 0.012 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0124 | 0.0337 | 0.797 |
Brugia malayi | Protein kinase domain containing protein | 0.0535 | 0.5319 | 0.5319 |
Echinococcus multilocularis | rho associated protein kinase | 0.0303 | 0.2507 | 0.814 |
Schistosoma mansoni | serine/threonine protein kinase | 0.035 | 0.308 | 0.579 |
Loa Loa (eye worm) | CMGC/DYRK/HIPK protein kinase | 0.035 | 0.308 | 0.308 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0535 | 0.5319 | 1 |
Loa Loa (eye worm) | CAMK/CAMKL/CHK1 protein kinase | 0.0535 | 0.5319 | 0.5319 |
Loa Loa (eye worm) | camk/mapkapk/mnk protein kinase | 0.0409 | 0.3794 | 0.3794 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0124 | 0.0337 | 0.797 |
Leishmania major | protein kinase, putative | 0.0131 | 0.0423 | 1 |
Plasmodium falciparum | protein serine/threonine kinase-1 | 0.0131 | 0.0423 | 1 |
Brugia malayi | probable protein kinase | 0.0181 | 0.103 | 0.103 |
Entamoeba histolytica | protein kinase domain containing protein | 0.035 | 0.308 | 1 |
Onchocerca volvulus | Serine\/threonine protein kinase homolog | 0.033 | 0.284 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 16 % | Effect on urine volume in rat 10 mg/kg, po relative to control | ChEMBL. | 17855087 |
Inhibition (binding) | = -8 % | Displacement of [3H]Manning ligand from human vasopressin V1a receptor expressed in CHO cells at 1000 nM | ChEMBL. | 17855087 |
Inhibition (binding) | = -8 % | Displacement of [3H]Manning ligand from human vasopressin V1a receptor expressed in CHO cells at 1000 nM | ChEMBL. | 17855087 |
Inhibition (binding) | = -4 % | Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells at 1000 nM | ChEMBL. | 17855087 |
Inhibition (binding) | = -4 % | Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells at 1000 nM | ChEMBL. | 17855087 |
Inhibition (binding) | = 16 % | Displacement of [3H]AVP from human vasopressin V2 receptor expressed in CHO cells at 1000 nM | ChEMBL. | 17855087 |
Inhibition (binding) | = 16 % | Displacement of [3H]AVP from human vasopressin V2 receptor expressed in CHO cells at 1000 nM | ChEMBL. | 17855087 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.